Clearstead Advisors’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-181
Closed -$5.37K 2101
2024
Q2
$5.37K Buy
181
+132
+269% +$3.66K ﹤0.01% 1677
2024
Q1
$1.3K Hold
49
﹤0.01% 1376
2023
Q4
$1.4K Sell
49
-4,419
-99% -$130K ﹤0.01% 1347
2023
Q3
$166K Buy
4,468
+2,234
+100% +$85.3K ﹤0.01% 611
2023
Q2
$87.1K Buy
+2,234
New +$87.5K 0.01% 608

Other funds holding RTO

Clearstead Advisors's RTO Position: Q3 2024 in Review

Clearstead Advisors sold out of Rentokil (RTO) in Q3 2024, closing a stake of 181 shares — an estimated $5.37K sold.

Clearstead Advisors first reported a position in RTO in Q2 2023 and held it in 5 quarters. The position peaked at $166K in Q3 2023. 220 funds tracked by Wall St. Rank hold RTO as of Q3 2024.

  • Clearstead Advisors reported no remaining Rentokil position as of Q3 2024 after selling out during the quarter.
  • Clearstead Advisors sold 181 Rentokil shares in Q3 2024, an estimated $5.37K.
  • Clearstead Advisors first reported a position in Rentokil in Q2 2023 and held it in 5 quarters.
  • Clearstead Advisors's Rentokil position peaked at $166K in Q3 2023.
  • 220 funds tracked by Wall St. Rank held Rentokil as of Q3 2024.

Based on Clearstead Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.